Finance

Beta
Lists
ACTU:NASDAQ
Actuate Therapeutics Inc
$1.58
-5.95%
(-0.100) 1D
Jun 29, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ACTU...
Open
$1.73
High
$1.76
Low
$1.46
Mkt. cap
37.80M
Avg. vol.
162.02K
Volume
0.00
52-wk high
$9.22
52-wk low
$1.46
EPS
-$0.99
Shares outstanding
23.93M
No. of employees
12
Open
$1.73
High
$1.76
Low
$1.46
Mkt. cap
37.80M
Avg. vol.
162.02K
Volume
0.00
52-wk high
$9.22
52-wk low
$1.46
EPS
-$0.99
Shares outstanding
23.93M
No. of employees
12
News stories
From sources across the web
About Actuate Therapeutics Inc
CEO-
Employees12
Founded2015
HeadquartersFort Worth, Texas, United States
SectorBiotechnology
Websiteactuatetherapeutics.com
Analyst ratings
Based on 3 analysts giving stock ratings to ACTU in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ACTU in the last 3 months.
Highest
Current $1.58
$15.00 (+849.37%)
Average
$10.67 (+575.32%)
Lowest
$5.00 (+216.46%)
Analyst
Recommendation
Action
Price target
Projected
Date
Swayampakula Ramakanth
H.C. Wainwright
Buy
Reiterated
$15.00
+849.4%
06/10/2026
Christopher Liu
Lucid Capital
Buy
Maintained
$5.00
+216.5%
05/18/2026
Albert Lowe
Craig-Hallum
Buy
Maintained
$12.00
+659.5%
05/12/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2.76M
2.18M
2.13M
2.57M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.20M
3.29M
2.56M
3.14M
Operating expense
5.97M
5.47M
4.69M
5.71M
Total operating expenses
5.97M
5.47M
4.69M
5.71M
Operating income
-5.97M
-5.47M
-4.69M
-5.71M
Other non operating income
-
-
-
-
EBT including unusual items
-5.95M
-5.41M
-4.55M
-5.63M
EBT excluding unusual items
-5.95M
-5.41M
-4.55M
-5.63M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-5.95M
-5.41M
-4.55M
-5.63M
Net profit margin
-
-
-
-
Earnings per share
-0.30
-0.25
-0.18
-0.24
Interest and investment income
24.53K
69.97K
139.58K
85.27K
Interest expense
-5.06K
-5.06K
-5.06K
-5.06K
Net interest expenses
19.47K
64.91K
134.52K
80.21K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create portfolio
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer